SAM
ONC

Smartleaf Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Smartleaf Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.96K Hold
24
– – ﹤0.01% 2540
2026
Q1 		$6.82K Sell
24
-1
-4% -$324 ﹤0.01% 2510
2025
Q4 		$7.62K Buy
25
+9
+56% +$2.95K ﹤0.01% 2511
2025
Q3 		$5.33K Buy
16
+12
+300% +$3.64K ﹤0.01% 2358
2025
Q2 		$964 Hold
4
– – ﹤0.01% 2487
2025
Q1 		$1.07K Hold
4
– – ﹤0.01% 2587
2024
Q4 		$735 Sell
4
-12
-75% -$2.45K ﹤0.01% 2722
2024
Q3 		$3.49K Buy
+16
New +$2.88K ﹤0.01% 2273

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Smartleaf Asset Management's ONC Position: Q2 2026 in Review

Smartleaf Asset Management held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 24 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2540.

Smartleaf Asset Management first reported a position in ONC in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.62K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Smartleaf Asset Management held 24 shares of BeOne Medicines Ltd worth $6.96K as of Q2 2026.
  • Smartleaf Asset Management left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2540 holding.
  • Smartleaf Asset Management first reported a position in BeOne Medicines Ltd in Q3 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's BeOne Medicines Ltd position peaked at $7.62K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.